Prostate cancer - 6th International Congress.
Figg
William D
WD
Molecular Pharmacology Section, Cancer Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. wdfigg@helix.nih.gov
Ockers
Sandra
S
D015703:Antigens, CD / Q000096:biosynthesis / Q000276:immunology; D000943:Antigens, Differentiation / Q000096:biosynthesis / Q000276:immunology; D060908:CTLA-4 Antigen; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D019496:Cancer Vaccines